| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/02/2007 | EP1778211A1 Methods and materials for treating mental illness |
| 05/02/2007 | EP1778208A1 Extended-release capsules comprising venlafaxine hydrochloride |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1552834B1 N-acetyl-l-pipecolic acid as neurotrophic factor production promoter |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1546134B1 Piperazine substituted aryl benzodiazepines |
| 05/02/2007 | EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 05/02/2007 | EP1492546B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 05/02/2007 | EP1488801B1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases |
| 05/02/2007 | EP1471871B1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
| 05/02/2007 | EP1451197B1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 05/02/2007 | EP1418905B1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/02/2007 | EP1414824B1 Novel anticonvulsant derivative salts |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
| 05/02/2007 | EP1311248B1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 05/02/2007 | EP1268478B1 Phenyl-substituted imidazopyridines |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1228052B1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1121115B1 Pufa supplements |
| 05/02/2007 | EP0831827B1 Novel formulations for transdermal delivery of pergolide |
| 05/02/2007 | CN1956983A 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 05/02/2007 | CN1956977A Pharmaceutical dosage forms and compositions of 5-HT1a receptor antagonists |
| 05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
| 05/02/2007 | CN1956965A Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high CB1/CB2 receptor subtype selectivity |
| 05/02/2007 | CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics |
| 05/02/2007 | CN1956959A Therapeutic compounds: pyridine N oxide scaffold |
| 05/02/2007 | CN1956958A Aminopyridine derivatives as selective dopamine d3 agonists |
| 05/02/2007 | CN1956955A Neurogenic pain control agent composition |
| 05/02/2007 | CN1956953A Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 05/02/2007 | CN1956952A Histamine H3 receptor agents, preparation and therapeutic uses |
| 05/02/2007 | CN1956715A Novel use of peptide compounds for treating dyskinesia |
| 05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955179A [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/02/2007 | CN1955159A Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use |
| 05/02/2007 | CN1954880A Anshenbunao granule and its preparation method |
| 05/02/2007 | CN1954876A Traditional Chinese medicine for treating epilepsy disease |
| 05/02/2007 | CN1954875A Medicine for give-up drug |
| 05/02/2007 | CN1954862A Syrup for treating headache |
| 05/02/2007 | CN1954861A Liquor for treating headache |
| 05/02/2007 | CN1954860A Emusion for treating headache |
| 05/02/2007 | CN1954842A Honey polygala root and its preparation method |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313463C Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313138C Chinese traditional medicine preparation for curing parkinsonism |
| 05/02/2007 | CN1313112C Medicinal composition with nourishing and tranquilizing |
| 05/02/2007 | CN1313105C Pharmaceutical composition for treating angioneurotic migraine |
| 05/02/2007 | CN1313092C Sustained-release tablet composition of pramipexole |
| 05/02/2007 | CN1313090C Aotomatic controlling nurve regulator and its health drinks and foods |
| 05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211602 Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
| 05/01/2007 | US7211574 Central nervous system disorders; eating disorders; antidiabetic agents |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211434 Activating cell differentiation in stem cells; obtain stem cells, culture in nutrient broth, monitor and evaluate differentiation |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211387 DNA molecule encoding a variant paraoxonase and uses thereof |
| 05/01/2007 | US7211262 Burn pain treatment by peripheral administration of a neurotoxin |
| 05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211251 Antibodies to transferrin receptor-like proteins |
| 05/01/2007 | CA2431397C Self emulsifying lipid matrix (selm) |
| 05/01/2007 | CA2350794C Use of agonists of glucocorticosteroid receptors and/or mineral corticosteroid receptors, especially corticosteroids to treat addictions |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 05/01/2007 | CA2189524C Aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino-[2,3e]indol-8-ones and derivatives |
| 05/01/2007 | CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 05/01/2007 | CA2176960C Novel carbamate compounds and processes for preparing the same |
| 05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 04/30/2007 | CA2564316A1 Slc1a1 marker for anxiety disorder |
| 04/30/2007 | CA2554874A1 Methods of reducing alcohol-induced dose dumping for hydromorphone sustained release oral dosage forms |
| 04/30/2007 | CA2554693A1 Methods of reducing alcohol-induced dose dumping for oxymorphone sustained release oral dosage forms |
| 04/26/2007 | WO2007047881A2 Method for treating neuropathic pain |
| 04/26/2007 | WO2007047820A1 Method for treating pain |
| 04/26/2007 | WO2007047737A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007046554A1 Process for production of dibenzoxepinopyrrole compound, intermediate for production of the compound, and process for production of the intermediate |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007046548A1 Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |